Loading...
XHKG
0157
Market cap135mUSD
Jun 16, Last price  
0.53HKD
1D
0.00%
1Q
9.28%
Jan 2017
-33.75%
IPO
-27.40%
Name

Natural Beauty Bio-Technology Ltd

Chart & Performance

D1W1MN
P/E
—
P/S
3.00
EPS
—
Div Yield, %
—
Shrs. gr., 5y
—
Rev. gr., 5y
-4.21%
Revenues
354m
+5.25%
357,916,000363,746,000450,147,000592,701,000538,092,000485,389,000591,295,000483,438,000439,421,000505,761,000506,913,000475,225,000399,579,000369,525,000438,413,000410,673,000487,810,000335,880,000336,015,000353,651,000
Net income
-104m
L+585.69%
81,011,000122,812,000178,707,000238,477,000149,636,00031,303,000115,123,000119,268,00058,269,00071,480,000136,830,000148,403,000105,388,00026,259,00021,908,0007,758,00035,264,000-30,472,000-15,111,000-103,615,000
CFO
-14m
L
111,678,000106,152,000274,198,000269,288,000154,091,000173,890,000170,374,00059,537,000108,289,000165,103,000140,084,000127,952,00021,176,00073,983,00020,316,00030,089,00042,781,0008,326,00021,724,000-13,746,000
Dividend
Jun 01, 20220.003 HKD/sh

Profile

Natural Beauty Bio-Technology Limited, an investment holding company, offers skin care products and services in in the People's Republic of China, Taiwan, and internationally. The company manufactures and sells skin care, beauty, aroma-therapeutic, cosmetics, health supplements, and make-up products under the Natural Beauty brand. It also offers skin treatment, beauty and spa, medical cosmetology, skin care consulting, and beauty consulting and training services. In addition, the company's spas provide hydrotherapy, facial treatment, body care, and skin care analysis services. Further, it engages in the wholesale of skin care and beauty products. The company was founded in 1976 and is based in Wan Chai, Hong Kong.
URL
http://www.ir-cloud.com/hongkong/00157/irwebsite/
IPO date
Mar 28, 2002
Employees
429
Domiciled in
HK
Incorporated in
KY

Valuation

Title
HKD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
353,651
5.25%
336,015
0.04%
335,880
-31.15%
Cost of revenue
402,707
343,394
380,002
Unusual Expense (Income)
NOPBT
(49,056)
(7,379)
(44,122)
NOPBT Margin
Operating Taxes
(1,592)
3,242
6,924
Tax Rate
NOPAT
(47,464)
(10,621)
(51,046)
Net income
(103,615)
585.69%
(15,111)
-50.41%
(30,472)
-186.41%
Dividends
(6,006)
Dividend yield
0.55%
Proceeds from repurchase of equity
BB yield
Debt
Debt current
74,299
171,737
119,408
Long-term debt
157,707
29,030
24,070
Deferred revenue
24,070
Other long-term liabilities
(6,024)
Net debt
115,499
(183,726)
(253,845)
Cash flow
Cash from operating activities
(13,746)
21,724
8,326
CAPEX
(41,211)
(69,116)
(44,309)
Cash from investing activities
(40,172)
(67,607)
(43,980)
Cash from financing activities
15,342
42,628
18,097
FCF
(46,382)
(46,147)
172,780
Balance
Cash
116,507
166,805
168,609
Long term investments
217,688
228,714
Excess cash
98,824
367,692
380,529
Stockholders' equity
135,716
502,966
525,904
Invested Capital
560,898
393,119
352,876
ROIC
ROCE
EV
Common stock shares outstanding
2,002,101
2,002,101
2,002,101
Price
0.49
1.04%
0.48
-12.73%
0.55
-3.51%
Market cap
971,019
1.04%
961,008
-12.73%
1,101,156
-3.51%
EV
1,086,518
777,282
847,311
EBITDA
(17,389)
19,271
(9,823)
EV/EBITDA
40.33
Interest
8,045
8,131
6,175
Interest/NOPBT